Cooperation between "" and""
SAN DIEGO, June 26 / WAM / The Department of Health – Abu Dhabi and Boehringer Ingelheim, one of the leading global companies in developing biopharmaceuticals, signed a strategic cooperation agreement to benefit from the advanced genomics system in Abu Dhabi, in a way that supports the future of precision medicine in the UAE, and contributes to reaching advanced scientific insights into the genetic factors that cause diseases.
The memorandum of understanding was signed during the Global Biotechnology Innovation Conference 2026, which was held in San Diego, USA, in the presence of Her Excellency Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, and was signed by Dr. Mohammed Al Amiri, Director of the Genome and Biobanking Department at the Department of Health – Abu Dhabi, and Ghaleb Al-Ahdab, Director of Public and Government Affairs in the Near East and the UAE Region at Boehringer Ingelheim.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
